Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gonal-f PEN in idiopathic male infertility: effect on sperm DNA fragmentation
2010-020196-23Phase 2Completed
- Sponsor
- Merck Serono
- Start
- Feb 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of follitropin alfa in unexplained male infertility (UMI), sponsored by Merck Serono. Primary endpoint: Change from baseline in sperm DNA fragmentation. Started Feb 2011; status: completed.
02
Drugs
follitropin alfa
03
Conditions
unexplained male infertility (UMI)
Beyond the preview
Go deeper on 2010-020196-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020196-23.